title: T cells contribute to stroke-induced lymphopenia in rats.
abstract: Stroke-induced immunodepression (SIID) results when T cell and non-T immune cells, such as B cells, NK cells and monocytes, are reduced in the peripheral blood and spleen after stroke. We investigated the hypothesis that T cells are required for the reductions in non-T cell subsets observed in SIID, and further examined a potential correlation between lymphopenia and High-mobility group protein B1 (HMGB1) release, a protein that regulates inflammation and immunodepression. Our results showed that focal ischemia resulted in similar cortical infarct sizes in both wild type (WT) Sprague Dawley (SD) rats and nude rats with a SD genetic background, which excludes the possibility of different infarct sizes affecting SIID. In addition, the numbers of CD68-positive macrophages in the ischemic brain did not differ between WT and nude rats. Numbers of total peripheral blood mononuclear cells (PBMCs) or splenocytes and lymphocyte subsets, including T cells, CD4(+) or CD8(+) T cells, B cells and monocytes in the blood and spleen, were decreased after stroke in WT rats. In nude rats, however, the total number of PBMCs and absolute numbers of NK cells, B cells and monocytes were increased in the peripheral blood after stroke; nude rats are athymic therefore they have few T cells present. Adoptive transfer of WT splenocytes into nude rats before stroke resulted in lymphopenia after stroke similar to WT rats. Moreover, in vitro T cell proliferation stimulated by Concanavalin A was significantly inhibited in WT rats as well as in nude rats receiving WT splenocyte adoptive transfer, suggesting that T cell function is indeed inhibited after stroke. Lastly, we demonstrated that stroke-induced lymphopenia is associated with a reduction in HMGB1 release in the peripheral blood. In conclusion, T cells are required for stroke-induced reductions in non-T immune cells and they are the most crucial lymphocytes for SIID.
authors.affiliation: Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
authors.forename: Lijuan
authors.initials: L
authors.lastname: Gu
authors.forename: Xiaoxing
authors.initials: X
authors.lastname: Xiong
authors.forename: Dingtai
authors.initials: D
authors.lastname: Wei
authors.forename: Xuwen
authors.initials: X
authors.lastname: Gao
authors.forename: Sheri
authors.initials: S
authors.lastname: Krams
authors.forename: Heng
authors.initials: H
authors.lastname: Zhao
mesh_terms: D000818:Animals; D020520:Brain Infarction / Q000209:etiology / Q000276:immunology / Q000473:pathology; D001947:Breeding; D049109:Cell Proliferation / Q000187:drug effects; D019695:Glycyrrhizic Acid / Q000494:pharmacology; D024243:HMGB1 Protein / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism; D008231:Lymphopenia / Q000209:etiology* / Q000276:immunology* / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D008297:Male; D051381:Rats; D013045:Species Specificity; D013154:Spleen / Q000276:immunology; D020521:Stroke / Q000150:complications*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D019737:Transplants
chemical_list: D024243:HMGB1 Protein; D019695:Glycyrrhizic Acid
references.citation: Immunity. 2002 May;16(5):619-22
references.pmid: 12049714
references.citation: J Exp Med. 2004 Nov 15;200(10):1221-30
references.pmid: 15534371
references.citation: Immunol Rev. 2007 Dec;220:47-59
references.pmid: 17979839
references.citation: J Neurosci. 2008 Nov 12;28(46):12023-12031
references.pmid: 19005067
references.citation: Neuroscience. 2009 Feb 6;158(3):1098-111
references.pmid: 18597949
references.citation: Immunol Rev. 2006 Jun;211:39-48
references.pmid: 16824115
references.citation: J Exp Med. 2009 Apr 13;206(4):751-60
references.pmid: 19332874
references.citation: Stroke. 2012 Jul;43(7):1941-6
references.pmid: 22678086
references.citation: Blood. 2001 Nov 15;98(10):3035-41
references.pmid: 11698288
references.citation: J Immunol. 2011 Sep 1;187(5):2155-61
references.pmid: 21821800
references.citation: Transplantation. 2006 Apr 15;81(7):1063-6
references.pmid: 16612285
references.citation: Exp Anim. 1998 Jan;47(1):63-7
references.pmid: 9498115
references.citation: Nat Rev Neurosci. 2005 Oct;6(10):775-86
references.pmid: 16163382
references.citation: Stroke. 2011 Jan;42(1):53-8
references.pmid: 21088239
references.citation: Stroke. 2009 Aug;40(8):2849-58
references.pmid: 19443795
references.citation: J Clin Lab Immunol. 1991 Aug;35(4):171-6
references.pmid: 1668853
references.citation: JAMA. 1973 Jun 11;224(11):1493-5
references.pmid: 4739951
references.citation: Neuroscience. 2009 Feb 6;158(3):1174-83
references.pmid: 18619524
references.citation: J Immunol. 2011 Jan 1;186(1):471-8
references.pmid: 21131425
references.citation: Science. 2011 Oct 7;334(6052):101-5
references.pmid: 21921158
references.citation: Am J Respir Crit Care Med. 2005 Jan 15;171(2):115-20
references.pmid: 15516533
references.citation: Nat Med. 2011 Jul 07;17(7):796-808
references.pmid: 21738161
references.citation: Annu Rev Immunol. 2008;26:741-66
references.pmid: 18173374
references.citation: J Exp Med. 2003 Sep 1;198(5):725-36
references.pmid: 12939340
references.citation: Cerebrovasc Dis. 2009;28(5):490-8
references.pmid: 19752550
references.citation: J Cereb Blood Flow Metab. 2006 Sep;26(9):1114-21
references.pmid: 16736038
references.citation: Transl Stroke Res. 2010 Sep;1(3):202-9
references.pmid: 21804899
references.citation: J Med. 1996;27(3-4):171-5
references.pmid: 8982964
references.citation: J Neurosci Res. 2008 Aug 1;86(10):2227-34
references.pmid: 18381759
references.citation: Shock. 2009 Mar;31(3):322-9
references.pmid: 18665051
references.citation: Stroke. 2004 Jan;35(1):2-6
references.pmid: 14684767
references.citation: Stroke. 2008 Jan;39(1):237-41
references.pmid: 18048864
references.citation: Clin Lab Haematol. 1995 Dec;17(4):335-7
references.pmid: 8697729
references.citation: Nat Rev Neurol. 2012 Jun 05;8(7):401-10
references.pmid: 22664787
references.citation: Cytokine. 2011 Jun;54(3):296-304
references.pmid: 21419643
references.citation: J Neuroimmunol. 2009 Jan 3;206(1-2):112-7
references.pmid: 19058859
references.citation: PLoS One. 2010 Jan 14;5(1):e8718
references.pmid: 20090932
references.citation: J Cereb Blood Flow Metab. 2008 May;28(5):927-38
references.pmid: 18000511
references.citation: J Immunol. 2006 Jun 1;176(11):6523-31
references.pmid: 16709809
references.citation: Infect Disord Drug Targets. 2010 Apr;10(2):91-7
references.pmid: 20166972
references.citation: J Neurol Sci. 1979 Nov;43(3):455-64
references.pmid: 521839
references.citation: Eur Neurol. 1988;28(6):331-4
references.pmid: 3215209
references.citation: Clin Exp Immunol. 2008 Jun;152(3):456-63
references.pmid: 18422734
references.citation: Int Immunol. 2012 Aug;24(8):485-94
references.pmid: 22473704
references.citation: Biol Pharm Bull. 2001 Aug;24(8):906-11
references.pmid: 11510483
references.citation: Cerebrovasc Dis. 2008;25(1-2):50-8
references.pmid: 18033958
references.citation: Stroke. 2009 Oct;40(10):3226-32
references.pmid: 19661470
references.citation: PLoS One. 2012;7(2):e30892
references.pmid: 22347410
references.citation: Neuroscience. 2009 Feb 6;158(3):1184-93
references.pmid: 18722511
references.citation: J Neurosci. 2005 Oct 19;25(42):9794-806
references.pmid: 16237183
references.citation: Neuroimmunomodulation. 2009;16(3):213-8
references.pmid: 19246945
references.citation: J Neurosci. 2006 Jun 14;26(24):6413-21
references.pmid: 16775128